Grade My Investments

CapsoVision, Inc. (CV) Stock Grade

CV · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$345.7M
P/E Ratio
—
Revenue Growth (YoY)
+15.3%
Net Margin
-186.8%
Return on Equity
—
Dividend Yield
None

About CapsoVision, Inc.'s fundamentals

CapsoVision is a medical device company with a market capitalization of $345.7 million that is growing revenue at a healthy 15.3% year-over-year rate. However, the company is currently unprofitable, with a net margin of -186.8%, meaning it is losing significantly more money than it generates in revenue. The company does not pay a dividend and reported a net loss in its latest annual statement. This growth-stage profile reflects a company investing heavily in development and commercialization while not yet achieving profitability.

Track CV free — no credit card required. Live grade + monthly AI report →